TRIOP
Financiado
TRIOP: an intraoperative probe to assess tumor margins and remove tumor residues...
TRIOP: an intraoperative probe to assess tumor margins and remove tumor residues in real time
Cancer is the 2nd most common cause of death worldwide. Oncological surgery is the most efficient single-treatment and is the most used as primary treatment. However, the local cancer recurrence rate after the first surgery is sti...
Cancer is the 2nd most common cause of death worldwide. Oncological surgery is the most efficient single-treatment and is the most used as primary treatment. However, the local cancer recurrence rate after the first surgery is still high in every organ. Local cancer recurrence is mainly caused by tumor growth from remaining tumor residues. They have a major impact on survival, quality of life and require reinterventions and/or adjuvant treatments. Therefore, the main issue today in oncological surgery today is to ensure the resection quality and remove the whole tumor while minimizing healthy tissues removal. To achieve it, surgeons need real time information on tumor residues’ location.
Beams is a medtech company, incorporated on the 17th of May 2021 to answer this unmet medical need. Beams develops TRIOP (Tumor Resection IntraOperative Probe) technology, a miniaturized intraoperative probe which measures the accumulation of existing radiotracers in tumor tissues after their injection in the organism, and then informs surgeons in real time about the precise tumor localization to help removing the tumor while preserving surrounding healthy tissues. The targeted impact is to prevent local cancer recurrence and to preserve patients’ quality of life.
The first Beams’ product based on TRIOP technology will be a multi-purpose intelligent surgical aspirator: the detection system will be built around an aspiration tool, to remove tumor cells, blood and other secretions that could alter the detection simultaneously with examining the operative cavity.
ver más
Duración del proyecto: 6 meses
Fecha Inicio: 2023-06-02
Fecha Fin: 2023-12-31
Fecha Fin: 2023-12-31
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-12-31
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
HORIZON-EIE-2022-SCALEUP-02-02:
Women TechEU
Cerrada
hace 2 años
Presupuesto
El presupuesto total del proyecto asciende a
75K€
Líder del proyecto
BEAMS
No se ha especificado una descripción o un objeto social para esta compañía.
